Neurological manifestations of systemic lupus erythematosus

March 3, 2026
87
УДК:  616-002.52:616.89-008]-071.2-072
Specialities :
Resume

The article is devoted to the study of neurological and neuropsychological symptoms of systemic lupus erythematosus (SLE), which are one of the most frequent and typical manifestations of the disease. However, despite the widespread prevalence of these disorders, there is currently no unified view on their classification, structure and prevalence. Aim: to characterize the neurological and neuropsychological symptoms of patients with SLE. Object of the study: neurological and neuropsychological symptoms in 64 patients with SLE. Results. The time interval from the debut of SLE to the development of neurological manifestations ranged from 0 days to 35 years and was 38.5 months (15.0; 62.0) on the median. In 26.56% of patients, the first clinical manifestations of SLE coincided with the onset of neurological symptoms, i.e. in more than a quarter of the examined, the disease debuted precisely with neurological disorders. In the structure of neurological symptoms, the leading positions in terms of specific weight were occupied by the following manifestations (in decreasing order of frequency): fatigue (8.4%), decreased concentration of attention (8.2%), headache (8.0%), anxiety (7.4%), memory impairment (7.4%) and depressed mood (7.0%). The least common were pain in the extremities (3.6%), epileptic paroxysms (3.2%) and hyperkinesis (1.0%). Conclusions. Neuropsychiatric symptoms are one of the typical manifestations of SLE. Neurological manifestations in SLE are characteri­zed by variability in the time of onset and significant clinical heterogeneity. In more than a quarter of patients, the disease debuts with neurological symptoms. Patients with neuropsychiatric SLE are characterized by pronounced polysymptoms.

References

  • 1. Aringer M., Costenbader K., Daikh D. et al. (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann. Rheum. Dis., 78(9): 1151–1159. doi.org/10.1136/annrheumdis-2018-214819.
  • 2. Fanouriakis A., Kostopoulou M., Anders H.-J. et al. (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann. Rheum. Dis., 83(1): 15–29. doi.org/10.1136/ard-2023-224762.
  • 3. American College of Rheumatology Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1999) Arthritis Rheum. doi.org/10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F.
  • 4. Hanly J.G., Urowitz M.B., Su L. et al. (2010) Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann. Rheum. Dis., 69(3): 529–535. doi.org/10.1136/ard.2008.106351.
  • 5. Brey R.L., Holliday S.L., Saklad A.R. et al. (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology, 58(8): 1214–1220. doi.org/10.1212/WNL.58.8.1214.
  • 6. Meier A.L., Bodmer N.S., Wirth C. et al. (2021) Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study. Lupus, 30(10): 1565–1576. doi.org/10.1177/09612033211025636.
  • 7. Khan M.I., Qureshi H., Akhtar S. et al. (2023) Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: A systematic review and meta-analysis. Front. Psychiatr., 14: 1098734. doi.org/10.3389/fpsyt.2023.1098734.
  • 8. Alammari Y.M., Gaddoury M.A., Alaryni A.A. et al. (2023) An evaluation of neuropsychiatric manifestations in systemic lupus erythematosus patients in Saudi Arabia and their associated factors. Neurosciences, 28(3): 177–183. doi.org/10.17712/nsj.2023.3.20220127.
  • 9. Bortoluzzi A., Scirè C.A., Govoni M. (2018) Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus. Front. Med. (Lausanne), 5: 68. doi.org/10.3389/fmed.2018.00068.
  • 10. Hanly J.G., Urowitz M.B., Sanchez-Guerrero J. et al.; Systemic Lupus International Collaborating Clinics (2007) Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis rheum., 56(1): 265–273. doi.org/10.1002/art.22305.
  • 11. Jump R.L., Robinson M.E., Armstrong A.E. et al. (2005) Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J. Rheumatol., 32(9): 1699–1705.
  • 12. Ahn G.E., Ramsey-Goldman R. (2012) Fatigue in systemic lupus erythematosus. Int. J. Clin. Rheumatol., 7(2): 217–227. doi.org/10.2217/IJR.12.4.
  • 13. Patel V. (2024). The Challenge of Neuropsychiatric Systemic Lupus Erythematosus: From Symptoms to Therapeutic Strategies. Diagnostics (Basel), 14(11): 1186. doi.org/10.3390/diagnostics14111186.
  • 14. Bertsias G.K., Ioannidis J.P., Aringer M. et al. (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR Standing Committee for Clinical Affairs. Ann. Rheum. Dis., 69(12): 2074–2082. doi.org/10.1136/ard.2010.130476.